Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
400 CHF | +388.82% |
|
-.--% | -.--% |
28/06 | Merck: positive opinion for Winrevair in Europe | CF |
28/06 | Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension | DJ |
MarketScreener Strategies
Merck and Company : Leader in oncology, modest valuation | October 29, 2019 at 08:34 pm IST |
- Stock Market
- Equities
- MRK Stock
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Strategies